Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication

Table 1 Origin of the gene expression data used for the in silico analysis.

Sample set	Data repository accession number *	Number of samples	Reference to the corresponding publication
Neuroblastoma samples	E-MEXP-83	10	[41]
	GSE3960	22	[42]
Healthy peripheral nervous system samples	GSE1133	10	[43]
	GSE3526	8	NA
	GSE96	2	[44]
Healthy central nervous system samples	E-AFMX-2	27	[45]
	E-TABM-20	8	[46]
	GSE1133	38	[43]
	GSE1297	9	[47]
	GSE2164	87	[48]
	GSE2361	9	[49]
	GSE3526	184	NA
	GSE3960	1	[42]
	GSE5388	31	[50]
	GSE5389	11	[50]
	GSE6955	3	[51]
	GSE96	17	[44]

* Data sets with accession numbers E-MEXP-83, E-AFMX-2 and E-TABM-20 have been deposited at ArrayExpress Archive http://www.ebi.ac.uk/microarray-as/ae/, while all other data sets have been deposited at Gene Expression Omnibus http://www.ncbi.nlm.nih.gov/geo/.

ISSN: 1471-2407